ImmunityBio Inc Forecast, price target & analysts
ImmunityBio Inc Target price 2025 - Analyst rating & recommendation
ImmunityBio Inc Classifications & Recommendation:
ImmunityBio Inc Price Target
| Target Price | $12.19 |
| Price | $2.86 |
| Potential |
326.14%
register free of charge
|
| Number of Estimates | 4 |
|
4 Analysts have issued a price target ImmunityBio Inc 2026 .
The average ImmunityBio Inc target price is $12.19.
This is
326.14%
register free of charge
$30.00
948.95%
register free of charge
$4.75
66.08%
register free of charge
|
|
| A rating was issued by 4 analysts: 3 Analysts recommend ImmunityBio Inc to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the ImmunityBio Inc stock has an average upside potential 2026 of
326.14%
register free of charge
|
Sales and Margin forecast 2024, 2025 to 2028
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Million $ | 0.62 | 21.24 |
| 158.33% | 3,325.32% | |
| Net Margin | -129,250.73% | -2,624.97% |
| 57.20% | 97.97% |
4 Analysts have issued a sales forecast ImmunityBio Inc 2024 . The average ImmunityBio Inc sales estimate is
This results in the following potential growth metrics:
4 ImmunityBio Inc Analysts have issued a net profit forecast 2024. The average ImmunityBio Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.15 | -0.80 |
| 10.58% | 30.43% | |
| P/E | negative | |
| EV/Sales | 140.21 |
4 Analysts have issued a ImmunityBio Inc forecast for earnings per share. The average ImmunityBio Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the ImmunityBio Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
ImmunityBio Inc...
Current ImmunityBio Inc Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| D. Boral Capital | Locked ➜ Locked | Locked | Feb 19 2025 |
| D. Boral Capital | Locked ➜ Locked | Locked | Feb 14 2025 |
| D. Boral Capital | Locked ➜ Locked | Locked | Jan 30 2025 |
| D. Boral Capital | Locked ➜ Locked | Locked | Jan 27 2025 |
| D. Boral Capital | Locked ➜ Locked | Locked | Jan 16 2025 |
| BTIG | Locked ➜ Locked | Locked | Jan 10 2025 |
| D. Boral Capital | Locked ➜ Locked | Locked | Jan 06 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
D. Boral Capital: Locked ➜ Locked
|
Feb 19 2025 |
|
Locked
D. Boral Capital: Locked ➜ Locked
|
Feb 14 2025 |
|
Locked
D. Boral Capital: Locked ➜ Locked
|
Jan 30 2025 |
|
Locked
D. Boral Capital: Locked ➜ Locked
|
Jan 27 2025 |
|
Locked
D. Boral Capital: Locked ➜ Locked
|
Jan 16 2025 |
|
Locked
BTIG: Locked ➜ Locked
|
Jan 10 2025 |
|
Locked
D. Boral Capital: Locked ➜ Locked
|
Jan 06 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
